Investigation of HBV, HCV, and HIV seropositivity in healthcare workers of reproductive age
Öz
Anahtar Kelimeler
Destekleyen Kurum
Proje Numarası
Kaynakça
- 1. Beltrami EM, Williams IT, Shapiro CN, Champerland ME. Risk and management of blood-borne infections in health care workers. Clin Microbial Rev. 2000; 13: 385-407.
- 2. Shoaei P, Lotfi N, Hassannejad R, Yaran M, Ataei B, Kassaian N, et al. Seroprevalence of Hepatitis C Infection among Laboratory Health Care Workers in Isfahan, Iran. Int J Prev Med. 2012; 1: 146-9.
- 3. Lok ASF. Hepatitis B treatment: What we know now and what remains to be researched. Hepatology 2019; 3: 8-19.
- 4. Mishra D, Singh H, Gogate P, Bhushan P, Singh MK, Srivastav T, et al. Prevalence of incidental and total human immunodeficiency virus, hepatitis B and hepatitis C seropositivity among patients posted for cataract surgery at a tertiary care center in? India. Indian J Ophthalmol. 2022; 70: 400–4
- 5. Global Burden of Disease 2015 HIV Collaborators. Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2015: The Global Burden of Disease Study 2015. Lancet HIV. 2016; 3: 361–87
- 6. Tabak F, Yurdaydın C, Kaymakoğlu S et al., and Guidelines Study Group VH. Diagnosis, management and treatment of hepatitis B virus infection: Turkey 2017 Clinical Practice Guidelines. Turk J Gastroenterol. 2017; 28:73-83.
- 7. Özkan H. Epidemiology of chronic hepatitis B in Turkey. Euroasian j hepatogastroenterol 2018;8:73
- 8. Willy ME, Dhillon GL, Loewen NL, Wesley RA, Henderson DK. Adverse exposures and universal precautions practices among a group of highly exposed health professionals. Infect Control Hosp Epidemiol. 1990; 11: 351-6.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Acil Tıp
Bölüm
Klinik Araştırma
Yazarlar
Hülya Aladağ
*
0000-0001-7749-3649
Türkiye
Yayımlanma Tarihi
30 Aralık 2022
Gönderilme Tarihi
20 Kasım 2022
Kabul Tarihi
25 Kasım 2022
Yayımlandığı Sayı
Yıl 2022 Cilt: 4 Sayı: 3